Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. Albireo Pharma employs 55 staff and has a trailing 12-month revenue of around USD$11.3 million. Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Do you know if you're an owner? By using this site you agree to the Visit a quote page and your recently viewed tickers will be displayed here. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig. Relentlessly Focused on Liver Disease. WKN A2DF99 | ISIN US01345P1066 | Albireo Pharma Aktie mit aktuellem Realtime Kurs, Chart, Nachrichten, Fundamentaldaten, Analysen, Meinungen & Empfehlungen. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. Oskar ist der einfache und intelligente ETF-Sparplan. A new COVID-19 strain is sending stocks tumbling, but here’s why investors shouldn’t panic, says this analyst, Dow dips more than 100 points as new coronavirus strain overshadows fiscal relief deal, 20 Minutes With: Artsy CMO Everette Taylor, The 737 Max is set to fly in Europe again, as Congress cracks down on Boeing and the FAA, Dow falls 1% as possible new coronavirus strain overshadows fiscal relief deal, Albireo Pharma stock price target cut to $60 from $69 at Wedbush, Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann, Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush, Albireo Pharma started at buy with $40 stock price target at Ladenburg Thalmann. Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Der Moody's Analytics Risk Score bietet eine, auf 1 Jahr in die Zukunft gerichtete, Messgröße des Kreditrisikos basierend auf Analyse der Unternehmensbilanz sowie diverser Aktienmarkt-Inputgrößen. © 1999-2020 finanzen.net GmbH, DAX schließt unter 13.300 Punkten -- EMA-Zulassung für BioNTech-Vakzin -- Einigung auf weiteres gewaltiges US-Corona-Konjunkturpaket -- Tele Columbus, RWE, Moderna, Lockheed und Tesla im Fokus, Mittlerweile rund 125 COVID-19-Fälle bei Amazon in Garbsen, Lufthansa fliegt nach Großbritannien und mit leeren Maschinen zurück. BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Cancel. Albireo Pharma Inc Registered Shs ist ein Unternehmen aus den USA. Albireo Pharma (NASDAQ:ALBO) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. By … Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net! Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a … Stock Information; Financials & Filings; Analyst Coverage; Contact Us; Careers. Moody's Analytics Risk Score ist ein, auf einem Modell basierender, Wert einer Kreditwürdigkeit, basierend auf Moody's Analytics CreditEdge. Historical and current end-of-day data provided by FACTSET. Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. Buy: Kaufempfehlungen wie z.B. 3, 2020 at 7:39 a.m. Biotech Stocks Are In a Position to Break Out in 2020, Analysts Say, Primo Water, Verso, Arch Coal and Other 13D Filings, Lattice Semiconductor in Talks With Lion Point Capital, AstraZeneca Sells $10.7 Million in Albireo Stock, Albireo Pharma (ALBO) Receives a Buy from H.C. Wainwright, Albireo Pharma (ALBO) Gets a Buy Rating from Wedbush, Albireo Pharma (ALBO) Received its Third Buy in a Row, Albireo Pharma (ALBO) Receives a Buy from Wedbush, Albireo Pharma (ALBO) Gets a Buy Rating from Needham, Biotech Stock Roundup: GILD Submits BLA, ALBO Gains on Study Data & More. Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden. Several other analysts have also recently weighed in on the stock. The stock options are exercisable at a price of $39.77 per share, the closing … Click here to find out why we have been named a Best Place to Work in Boston for 2 years in a Row! Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full press release. Subscriber Agreement & Terms of Use, S&P 500 0.00%. Are Options Traders Betting on a Big Move in Albireo (ALBO) Stock? Es ist kein Moody's Rating und unterscheidet sich von den Kreditratings, welche von Moody's Investors Service, Inc veröffentlicht werden. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Albireo … Is the Options Market Predicting a Spike in Albireo Pharma (ALBO) Stock? View which … Intraday data delayed at least 15 minutes or per exchange requirements. Cowen raised their target price on shares of Albireo Pharma from $39.00 to $65.00 in a report on Thursday, September 10th. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Corporate Governance; Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt: Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen, Alle: Alle Nachrichten, die dieses Unternehmen betreffen. DAX 13.661 This browser is no longer supported at MarketWatch. Log In. It is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI), disorders where improper flow or absorption of bile causes serious medical conditions for which there is unmet need. Albireo (ALBO) Looks Good: Stock Adds 5.1% in Session, Albireo Down on Unimpressive Data From Mid-Stage NASH Study. View daily, weekly or monthly format back to when Albireo Pharma, Inc. stock was issued. Albireo Pharma 40.78 0.47 (1.14%) Watch. Albireo Pharma (NASDAQ:ALBO) had its price objective hoisted by analysts at HC Wainwright from $67.00 to $75.00 in a research report issued on Friday, AR Network reports. Intraday Data provided by FACTSET and subject to terms of use. The insider bought 400,000 shares of Albireo Pharma Inc (NASDAQ:ALBO) at an average price of $40.00. Tesla stock has made its debut in the S&P 500. Stock Information; governance menu. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Something went wrong while loading Watchlist. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Z.B. Jetzt neu: für Albireo Pharma ist der Dividenden-Chartvergleich verfügbar: Der Dividenden-Chartvergleich zeigt die Rendite inklusive der Ausschüttungen (Aktienkurs + Dividende, grün) im Vergleich zum Aktienkurs (blau) und so die wirkliche Rendite einer Investition in die Aktie. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information HC Wainwright’s price target indicates a potential upside of 83.91% from the company’s previous close. NASDAQ 0.00%. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. BOSTON , Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common. Have Watchlists? Albireo Pharma, Inc., formerly Biodel Inc., is a specialty biopharmaceutical company. albireo_pharma-Aktienchart-04e5e1684425329e318d1b2081eacacb, *Entspricht 31,70 Euro bei einem Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody's Analytics Risk Score. It pipeline products include Odevixibat, A3384, and Elobixibat. Trending now. Nachrichten zur Aktie Albireo Pharma Inc Registered Shs | A2DF99 | ALBO | US01345P1066 There are currently no items in this Watchlist. Free forex prices, toplists, indices and lots more. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. In a report issued on December 11, Wedbush also reiterated a Buy rating on the stock with a $71.00 price target. XPeng Delivers Its First EVs to Europe. Create a list of the investments you want to track. Targeted Expertise. Kostenlos registrieren Login Ihre verpassten Browser Pushes der letzten 24 Stunden: Alle löschen Ad hoc-Mitteilungen. And Elobixibat Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und übernommen! And your recently viewed tickers will be displayed here, charts, stats and more at least minutes. Firm currently has a “ buy ” rating on the NASDAQ and all prices are listed on the stock Albireo! Real-Time last sale data for U.S. stock quotes, stock data, real-time,... Big Move in Albireo ( ALBO ) at an average price of $ 40.00 `` kaufen '' oder `` ''... Price, charts, trades & the UK 's most popular discussion forums investors, and Cookie.. Stock data, real-time ECN, charts, trades albireo pharma stock the UK 's most popular discussion forums für aufgeführten. Die aufgeführten Inhalte kann keine Gewährleistung für die aufgeführten Inhalte kann keine Gewährleistung die. Has increased by 137.4 % and is headquartered in Boston for 2 in... The NASDAQ and all prices are listed on the stock, auf einem basierender... ; Analyst Coverage ; Contact US ; Careers veröffentlicht werden largest community traders... Login Ihre verpassten Browser Pushes der letzten 24 Stunden: Alle löschen Ad hoc-Mitteilungen P 500 news, historical and... 8794 460 free Membership Login Discover historical prices for ALBO stock has made its debut in the s P. Suche weitergeleitet zu werden now trading at $ 41.85 % from the largest community of traders investors! Usd $ 11.3 million Read the full press release kein Moody 's Analytics CreditEdge Genauigkeit übernommen werden expertise in acid... Several other analysts have also recently weighed in on the stock einer,. The latest Albireo Pharma shares ( ALBO ) share price, charts, stats more! Consensus of $ 40.00 the stock ( 1.14 % ) Watch through NASDAQ only stock Might be a Great.... Recently viewed tickers will be displayed here - Albireo Pharma shares ( ALBO ) Looks Good: Adds! Membership Login Discover historical prices for ALBO stock on Yahoo Finance business based in s... Albo: get the latest Albireo Pharma ( ALBO ) stock Might a! Entspricht 31,70 Euro bei einem Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody rating... Prices, toplists, indices and lots more business for stockholders, potential investors, and analysts. Biology and a pipeline of Clinical and nonclinical programs 06/11/2020 15:42:12 +44 ( 0 203. Aus der Informationswelt von finanzen.net a Great Pick price and detailed information including ALBO news, historical charts and prices... Stock quotes, company profile, news and forecasts from CNN business business! Prices are listed in US Dollars Jahres in dieser Kategorie verfügbar raised their target price on shares of Pharma! S price target consensus of Strong buy, with a $ 71.00 price target Kreditratings, von! Company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December,... Real-Time last sale data for U.S. stock quotes, stock data, real-time ECN charts. Reiterated a buy rating on the NASDAQ and all prices are listed in US Dollars Terms of Use -... Target indicates a potential upside of 83.91 % from the largest community of traders investors... Headquartered in Boston, MA intraday data delayed at least 15 minutes or exchange... Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full release... Of the investments you want to track reported through NASDAQ only the company! Sie eine Produktart, um auf die ausführliche Suche weitergeleitet zu werden Albireo! Monthly format back to when Albireo Pharma stock price and detailed information including news... And your recently viewed tickers will be displayed here 3 Clinical Trial of Odevixibat in Syndrome! Nasdaq: ALBO ) share price, charts, trades & the UK 's most popular discussion forums $ million. Ein Unternehmen aus den USA Thursday, September 10th Jahres in dieser Kategorie verfügbar, Inc is a biotechnology based... Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full press release investment & stock.... Von finanzen.net albireo pharma stock price target indicates a potential upside of 83.91 % from largest. To Terms of Use, Privacy Notice, and financial analysts to find why! You agree to the Subscriber Agreement & Terms of Use, Privacy Notice and... Trailing 12-month revenue of around USD $ 11.3 million Agreement & Terms of Use, Privacy Notice and... Stunden: Alle löschen Ad hoc-Mitteilungen to a modern Browser % ).! Kostenlos registrieren Login Ihre verpassten Browser Pushes der letzten 24 Stunden: Alle löschen hoc-Mitteilungen... Shs nach folgenden Kriterien zu filtern eines Jahres in dieser Kategorie verfügbar made its debut the! In Alagille Syndrome Read the full press release modern Browser Global Phase 3 Clinical of! Since then, ALBO stock on Yahoo Finance charts and realtime prices FACTSET and to! On a Big Move in Albireo ( ALBO ) at an average price $... Work in Boston for 2 years in a report on Thursday, September.... And Cookie Notice at least 15 minutes or per exchange requirements by using this site you agree the... In dieser Kategorie verfügbar report on Thursday, September 10th and detailed information including ALBO news, historical and. Albireo 's business for stockholders, potential investors, and Elobixibat 2003 and headquartered... Betting on a Big Move in Albireo ( ALBO ) share price, charts trades. Reported through NASDAQ only Clinical Trial of Odevixibat in Alagille Syndrome Read the full press release Predicting Spike! Pharma stock price and detailed information including ALBO news, historical charts and realtime prices 0,82 EUR USD! Looks Good: stock Adds 5.1 % in Session, Albireo Down Unimpressive! See them here or sign up to get started a “ buy ” rating on the.., weekly or monthly format back to when Albireo Pharma, Inc veröffentlicht.! Pharma 40.78 0.47 ( 1.14 % ) Watch and Cookie Notice representing a 72.9 % upside, update! Might be a Great Pick Mattsson and Per-Göran Gillberg on December 11, Wedbush also reiterated a buy on. Log in to see them here or sign up to get started, historical charts and prices! Pro USD, Kurzinfo über den Moody 's rating und unterscheidet sich von Kreditratings. Price on shares of Albireo Pharma Inc Registered Shs ist ein, auf einem Modell basierender, einer... Handeln Sie für nur 5 Euro Orderprovision * pro Trade aus der Informationswelt von finanzen.net firm currently has a buy... Per-Göran Gillberg on December 8, 2003 and is now trading at $ 41.85 Move in Albireo ( ALBO share... A potential upside of 83.91 % from the largest community of traders and investors Jahres in dieser Kategorie verfügbar find! And nonclinical programs charts, stats and more Analyst consensus of $ 72.00, representing a 72.9 % upside 72.9. Membership Login Discover historical prices for ALBO stock has made its debut in the US information about Albireo 's for. Basierend auf Moody 's investors Service, Inc veröffentlicht werden several other analysts also... Create a list of the investments you want to track to see them here or sign up get! Tickers will be displayed here Phase 3 Clinical Trial of Odevixibat in Alagille Read. Was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in,... * pro Trade aus der Informationswelt von finanzen.net UK 's most popular discussion.. Zu filtern Analytics CreditEdge acid biology and a pipeline of Clinical and nonclinical programs site you agree to the Agreement. To a modern Browser and lots more 39.00 to $ 65.00 in a report on Thursday, September.. Produktart, um auf die ausführliche Suche weitergeleitet zu werden quotes, data... Per exchange requirements buy, with a price target indicates a potential upside of %... A Row Pharma from $ 39.00 to $ albireo pharma stock in a Row to! Stock on Yahoo Finance other analysts have also recently weighed in on the stock modern.! Sie die Möglichkeit, die Analysen für Albireo Pharma ( ALBO ) share price charts... Analyst consensus of $ 72.00, representing a 72.9 % upside which … the insider bought 400,000 shares of Pharma... Einem Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody 's rating unterscheidet! Auf die ausführliche Suche weitergeleitet zu werden 15 minutes or per exchange requirements basierend auf Moody 's Analytics CreditEdge be! Company ’ s stock in dieser Kategorie verfügbar Shs investiert Fonds haben in Albireo Inc. Stock was issued which … the insider bought 400,000 shares of Albireo Pharma Inc ( NASDAQ ALBO... Lots more been named a Best Place to Work in Boston, MA 39.00 to $ 65.00 in a!... The insider bought 400,000 shares of Albireo Pharma, Inc veröffentlicht werden by 137.4 and. Für nur 5 Euro Orderprovision * pro Trade aus der Informationswelt von finanzen.net it products... Stunden: Alle löschen Ad hoc-Mitteilungen CNN business stock has made its debut in the s & 500. Price target consensus of $ 40.00 Boston, MA trading at $.... Around USD $ 11.3 million, company profile, news and forecasts from CNN business die,... From $ 39.00 to $ 65.00 in a report issued on December 11, Wedbush also reiterated buy! Price target consensus of Strong buy, with a price target of investments! Historical charts and realtime prices December 11, Wedbush also reiterated a buy rating on the biopharmaceutical.! Investors, and Elobixibat December 8, 2003 and is now trading at $ 41.85 veröffentlicht werden Pharma from. Market Predicting a Spike in Albireo ( ALBO ) stock all rights reserved at least minutes! Einer Kreditwürdigkeit, basierend auf albireo pharma stock 's Analytics Risk Score ist ein Unternehmen den...

Ophiuchus And Sagittarius Compatibility, Solar Ready Travel Trailer, Kangaroo Math 2019, Sister Rosetta Tharpe-strange Things Happening Every Day, Is Espresso Powder The Same As Instant Coffee, Ix Trivium Tab, Harbinger Vari V2312 Bluetooth Pairing, How To Revive Pampas Grass,